AU2003903474A0
|
|
Multiply charged oligosaccharide delivery
|
AU2003233258A1
|
|
Combinatorial oligosaccharide synthesis
|
AU2003900242A0
|
|
Compounds that interact with integrin receptors
|
AU2002952121A0
|
|
Novel carbohydrate based anti-bacterials
|
AU2002951995A0
|
|
Classes of compounds that interact with gpcrs
|
AU2002951247A0
|
|
Compounds that interact with kinases
|
AU2002950657A0
|
|
Derivatives of monosaccharides for drug discovery
|
AUPS339002A0
|
|
Multiply charged oligosaccharide delivery
|
AUPS290602A0
|
|
Combinatorial oligosaccharide synthesis
|
AUPS273602A0
|
|
Anti-pathogenic oligosaccharides
|
AUPS213802A0
|
|
Disaccharides for drug discovery
|
AUPS143402A0
|
|
Anomeric derivatives of monosaccharides
|
AU9528701A
|
|
Immunoadjuvant systems
|
AU9528201A
|
|
Combinatorial libraries of monosaccharides
|
AUPR533801A0
|
|
Anti-pathogenic oligosaccharides
|
IL150410D0
|
|
METHODS FOR SYNTHESIS OF α-D-GAL (1-3) GAL-CONTAINING OLIGOSACCHARIDES
|
AU2654201A
|
|
Methods for synthesis of alpha-D-GAL (1-3) GAL-containing oligosaccharides
|
GB0100115D0
|
|
Delivery systems
|
AUPR084400A0
|
|
Immunoadjuvant systems
|
AUPR079700A0
|
|
Combinatorial libraries of monosaccharides
|